Genzyme Trims 185 MA Jobs

Xconomy Boston — 

Cambridge, MA-based biotech Genzyme (NASDAQ: GENZ) revealed today that it will cut 185 jobs in the Bay State, as an initial implementation of its plan to trim 1,000 jobs across the company by the end of 2011, announced in September. Fifty-eight of the job reductions in Massachusetts will come from not filling open positions, and globally, the firm is cutting about 390 jobs this year. Genzyme said it is targeting $385 million in annual savings by 2012 through the job cuts and other cost-saving steps.